Retrospective Cohort Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Feb 21, 2017; 23(7): 1215-1223
Published online Feb 21, 2017. doi: 10.3748/wjg.v23.i7.1215
Table 3 Univariate and multivariate analyses for survival
n = 1135-yr survivalUnivariateMultivariate
P valueHR95%CIP value
Sex
Male65330.17-
Female4848
Comorbidities
< 293350.35-
≥ 22063
Operation
Total29360.13-
Others8441
Procedure
Open101370.10-
Laparoscopy1262
Lymphadenectomy
Radical59430.011.001.00-4.970.05
Limited54352.19
Operative time (min)
< 24076320.34-
≥ 2403358
Unknown4
Bleeding (g)
< 40091400.12-
≥ 4001827
Unknown4
cT
1-26349< 0.011.160.41-3.230.78
3-450271.00
cN
Absent67450.43-
Present4635
cStage
I-II87400.59-
III- IV2637
pT
1-26258< 0.011.001.29-20.70.02
3-451164.68
pN
Absent5856< 0.011.000.68-5.620.24
Present55231.84
pStage
I-II7855< 0.01-
III- IV359
Residual tumor
R0103410.061.140.39-3.870.81
R110311.00
Lymphatic invasion
Absent37550.091.490.43-5.100.53
Present67291.00
Unknown9
Venous invasion
Absent5358< 0.011.000.75-5.800.17
Present51152.00
Unknown9
Complications
Absent81340.31-
Present3251